Find the right fit for you - faster
Get tailored insights about working at MAP Pharmaceuticals in one quick step.
MAP Pharmaceuticals Snapshot
MAP Pharmaceuticals knows that a good drug can become a better drug when delivered quickly. The company has developed an inhalation technology and is applying it to existing drugs. Its two lead candidates include a treatment for migraine and a treatment for pediatric asthma. Inhaled drugs can be delivered conveniently and work more quickly than other delivery methods. The company's other candidates include possible treatments for diabetes and chronic obstructive pulmonary disease (COPD). By focusing on improving the delivery system rather than inventing the actual drug, MAP Pharmaceuticals hopes to reduce some of the risk of the development process.
